Mereo BioPharma (MREO) S-8 Registration of securities for employees

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Mereo BioPharma Group plc

London, United Kingdom

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 of Mereo BioPharma Group plc of our report dated March 31, 2022, relating to the consolidated financial statements of Mereo BioPharma Group plc which appears in the Company’s Annual Report on Form 20-F, which is incorporated by reference in this Registration Statement.

/s/ BDO LLP

BDO LLP

Reading, United Kingdom

January 24, 2023